Other news ‘Slap in the face’ for the disabled Varhelyi is not the only choice to have ruffled feathers. The European Disability Forum said it was “extremely outraged” by how the equality portfolio has been treated. “It is unbelievable that the proposal excludes a standalone portfolio on Equality,” said Yannis Vardakastanis, the president of the European Disability Forum. “We are outraged by this ‘downgrade’; it is a ‘slap in the face’ for millions of people and risks all the progress that the Commission has made so far regarding our rights. We urgently ask members of the European Parliament to lead the charge in restoring the position of Commissioner for Equality as a standalone portfolio.” Worrying wastewater The latest data from the 18 EU countries that monitor SARS-CoV-2 virus levels in wastewater indicate that six countries (Belgium, Germany, Denmark, Finland, Luxembourg, and Lativa) have shown an upward trend, which is a reliable indicator that COVID is more prevalent in the population. For Austria, Hungary and the Netherlands the situation is stable. Reassuring to know – at least for our Brussels readers – that Vivalis is rolling out its vaccination against COVID-19 and recommending seasonal flu vaccination. For more information click here. 39 million deaths – antimicrobial resistance is a global health emergency A new in-depth global analysis of the impact of antimicrobial resistance (AMR) published in The Lancet suggests more than 39 million deaths from antibiotic-resistant infections could occur between now and 2050. Despite the attention AMR has received at the global level, the report says that implementation and funding of national action plans has been uneven, leading to uncertain progress in attenuating the burden of AMR. Patients organisations and healthcare professionals The Commission has launched a selection procedure to appoint representatives of patients’ organisations and healthcare professionals in the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA). … and for advanced therapies There is also an open selection procedure to appoint the representatives of patients’ associations and clinicians for EMA’s Committee for Advanced Therapies. |